malic acid has been researched along with Arrhythmia in 1 studies
malic acid : A 2-hydroxydicarboxylic acid that is succinic acid in which one of the hydrogens attached to a carbon is replaced by a hydroxy group.
2-hydroxydicarboxylic acid : Any dicarboxylic acid carrying a hydroxy group on the carbon atom at position alpha to the carboxy group.
Excerpt | Relevance | Reference |
---|---|---|
"A mixture of mitochondrial substrates of succinic and malic acids more effectively than antihypoxant trimetazidine prevented functional and metabolic disorders in rat myocardium during acute ischemia: reduces T wave amplitude, QT interval, number and duration of arrhythmias, and restores oxidation-phosphorylation coupling." | 7.74 | Cardioprotective effects of trimetazidine and a combination of succinic and malic acids in acute myocardial ischemia. ( Chernyschova, GA; Khazanov, VA; Kiseliova, AA; Vasiliev, KY, 2008) |
"A mixture of mitochondrial substrates of succinic and malic acids more effectively than antihypoxant trimetazidine prevented functional and metabolic disorders in rat myocardium during acute ischemia: reduces T wave amplitude, QT interval, number and duration of arrhythmias, and restores oxidation-phosphorylation coupling." | 3.74 | Cardioprotective effects of trimetazidine and a combination of succinic and malic acids in acute myocardial ischemia. ( Chernyschova, GA; Khazanov, VA; Kiseliova, AA; Vasiliev, KY, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khazanov, VA | 1 |
Kiseliova, AA | 1 |
Vasiliev, KY | 1 |
Chernyschova, GA | 1 |
1 other study available for malic acid and Arrhythmia
Article | Year |
---|---|
Cardioprotective effects of trimetazidine and a combination of succinic and malic acids in acute myocardial ischemia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Coronary Occlusion; Drug | 2008 |